24 Burst results for "$56,000"
"$56,000" Discussed on Bloomberg Radio New York
"Bloomberg daybreak Europe. The economic environment is challenging. We have hot inflation, demand is slowing, and interest rates have been rising. The hope is that information is going to now start coming down. But this is only really one month. This is a very challenging economic situation here and across the world. And it will get worse before it gets better. Bloomberg daybreak, Europe, on Bloomberg radio. Good morning, everybody. It's just a 8 30 here in London. I'm Anna Edwards. And I'm Stephen Carol. This is Bloomberg daybreak Europe. We check the markets for every 50 minutes throughout the trading day here on Bloomberg radio, the stock 606 tenths of 1% lower this morning. The 4100 half a percent lower, the cat car aren't in Paris two thirds in the red, the Dax and Frankfurt down by four times as well. So equity markets continuing to suffer after the big sell off that we saw yesterday in the wake of those hawkish comments from the ECB in terms of the sectors on the stocks 600, almost everything just two sectors and positive territory auto and parts and banks seeking out some very small gains this morning, bottom of the basket, telecom shares down 1.6% real estate shares down 1.3% Wall Street futures also now firmly in the red S&P E minis 8 tenths of 1% lower that market closed down two and a half percent yesterday and a further sell off to across the European bond space the ten year bond yield in Germany now 9 basis points higher this morning after jumping by 14 basis points yesterday to 2.17 is where that's trading Italy's tenure BTP's 16 basis points higher this morning, 4.31 and we're seeing guilty as rise in the UK as well. Okay, so we continue to watch the bond markets and how they respond to the central banking hawkishness of this week. With that in mind, let's recap our top stories, the European Central Bank followed the fed with the 50 basis point hike yesterday, but sources tell Bloomberg more than a third of policymakers actually pushed for a bumper 75 point height once again. News of the split comes after the president of the European Central Bank Christine Lagarde said aggressive rate hikes are far from over. We should expect to raise interest rates at a 50 basis point pace for a period of time. ECB president Christine Lagarde also told the news conference that, quote, we have more ground to cover, we have longer to go and we are in for the long game. Eurozone inflation slowed in November for the first time in a year, and a year and a half, with prices rising by 10% year on year. The Bank of England says inflation may have peaked the Central Bank lifting its benchmark landing rate by half a point to three and a half percent, bringing interest rates to a 14 year high to time soaring prices. BOE governor Andrew Bailey says inflation risks remain tilted to the upside with the Central Bank determined to bring price rises back to its 2% target. We expect inflation to start falling more rapidly, probably from the late spring onwards. But there is a risk that it won't happen in that way, particularly because the labor market and the labor supply in this country are so tight. And that's why really we had to raise interest rates today because we see that risk is really quite pronounced. The bank's monetary policy committee split three ways under decision, 6 members including the governor Andrew Bailey voting for the half point rise. EU member states are said to have reached a deal on a night's package of sanctions on Russia, the measures will target Moscow's access to drones, additional Russian banks, as well as officials responsible for allegedly abducting children from Ukraine. The package will affect more than 100 individuals and dozens of entities. And in news of Elon Musk has some good news actually after a bruising few weeks, Tesla says it's building 3000 model Y SUVs a week at its new Austin Texas factory with more here's Bloomberg's Charlie palace. It's a sign that the electric carmaker is making up for lost time at the money losing plant, Tesla shared the new production number in a tweet, the milestone comes a week after Bloomberg news reported that CEO Elon Musk had asked the head of the company's China division to get the Austin factory up to speed, extrapolated out over a year that production rate would get Tesla to about 156,000 vehicles, which is still short of the annual target of 250,000, but the company promoted in its third quarter letter to shareholders. In New York, Charlie pellet, Bloomberg, daybreak, Europe. Does our top stories coming up next more on the markets will be joined by virginie Maison nerve, whose global equity CIO at Allianz global investors stay with us for that conversation
"$56,000" Discussed on Bloomberg Radio New York
"Jarvis who has a column on the Bloomberg right now revisiting the saga of Biogen's Alzheimer's degree Drug So Lisa thanks for being here We heard about this one FDA first approved it but there are new developments That's right Thank you for having me So what we're seeing now is that Medicare has said that it will only cover this drug if people are enrolled in a clinical trial That basically very very very narrowly limit the people who will have access to this drug And as I argued in my column was the right choice because FDA had approved this drug going against the advice of its advisers and based on very little evidence that it worked So one of the things I learned from your column I had heard there was expensive I'm not sure I knew how expensive it was but it is certainly about the safety and efficacy of the drug It's also about what it would do to the cost for subscribing to part B that's right The drag was initially priced at $56,000 per year Which stunned everyone because the evidence of it working was pretty minimal After a public outcry Biogen did cut that in half but this year there was a substantial increase in Medicare monthly premiums in large part due to concerns over how much this drug might affect the cost to the system Because there are somewhere between 1.5.
"$56,000" Discussed on KGO 810
"Yeah, it's you know, it's so funny technology we get. We were talking about the iPhone, you know? And now airplanes, there are things that we don't even give a second thought to That are absolutely technological marvels, and we use them every single day from your iPhone to the elevator that takes you to the 1/100 floor if you really think too much about the technology. It blows your mind. But when we're talking about airplanes, I mean what Boeing did, and again I urge you guys to watch the documentary. It's just You can't mess around with people's lives in that way, Just assuming that pilots are going to wonder what the hell is going on and try to adjust and lead to the tragedies. Sadly that we saw with the 7 37 Max. So again that documentaries airing tonight on PBS. I mean the standards to keep pilots licensed. Uh, they're pretty high. But the big knock has been within the industry the technology in the cockpit that makes them complacent over the years. Exactly. Exactly. Okay, let's talk about a different kind of scandal. Um So this week, opening statements were beginning in the college admissions scandal. Okay, And so this was it Wrangled. Lori Laughlin, Felicity Huffman. Some big names. There was a former Wynn Resorts executive, Gamal Abdel Aziz. Who paid $300,000 to get his daughter back in 2017 into USC as a basketball recruit, Okay? $300,000. I mean, in my mind, I'm like just by a wing or something, right? I mean donor name on a building and get your daughter in that way. But anyways, the reason I bring this up is one. I mean, the whole idea of Going to college and the cost of college is so astronomical, but also U. S. News and World Report came out with it Best National university rankings, Okay. Princeton came in at number one tuition and fears and I'm I think I'm right. It's each year. Right? $56,000, That's Columbia University. 63 $1000 a year. Basically buying a Tesla for four years. Harvard is lucky to get out. And four exactly. Exactly. Harvard is 55. So was Mitt. Okay, Yale. Almost $60,000 a year. Stanford University is 56. $1000 a year, So I kept scrolling down right and they and they kept loading up more of these these colleges for me. And so eventually where I got to one where they started actually giving you the comparison between in state and out of state tuition in the first one that they they put on this list that had the information Was number 20 on the list, and that was U C L. A University of California Los Angeles. Sure, if you're in state, it's pretty reasonable $13,000. Now I still think that's a heck of a lot of money for college, but When you compare it to out of state. $43,000 a year Now we live in California so we could pay in state tuition. But this is my question for you for 15 80 88 10. If you're saving for your kid's college if you're saving for your college Why would you ever go out of state or go to these big brand name colleges? Or you're spending 60 k a year? Why would you want to do that? What is the deciding factor is that the brand is that the name Is it really something that you feel like You can only get there. And if you have a kid that's like I know I live in California have made amazing colleges here, but I want to go to Missouri or fill in the blanks day with my best friend, and it's going to cost you three or four times as much. Why would you ever Say yes to that. 415 80 88 10. This is kgl. Good.
Biogen Shares Down 7%
"Today. That's after United Health Group said it needed more time to determine its coverage policy for the biotech companies recently approved $56,000 Alzheimer's disease, drug addled film that's expected to raise costs for the U. S government's Medicare program. It's official. The Emerald
Medicare Evaluating Coverage for $56,000 Alzheimer's Drug
"Medicare's lunch the process to decide if it will cover the cost of a new controversial Alzheimer's drug that's undergoing congressional scrutiny the new drug ad you helm is costly fifty six thousand dollars a year and there are questions still surrounding who it will help after the FDA had to scale back its recommended use right now Medicare's making case by case decisions on whether to cover the drug it may have a blanket answer sometime next year meanwhile Congress is intensifying its scrutiny of the drug's approval to committees of requested documents from drugmaker Biogen including those surrounding unusual contacts between company executives and FDA regulators there was a new analysis done after company study suggested add to home was ineffective at slowing mental decline Jackie Quinn Washington
"$56,000" Discussed on TalkRadio 630 KHOW
"After the FDA approved the drug, saying This is really not science anymore. I told you about my former brother in law who runs a hedge fund. He's a medical doctor, and he runs a hedge fund and they trade only healthcare stocks. He said. This was the death of science at the FDA when they approved this drug And multiple members of the committee. Designed for the same reason. So we got a story this morning. Clearly, the FDA is feeling the pressure. A lot of people do not understand why the FDA did what they did. Here's a headline from Yesterday. U. S health regulators narrowed the prescribing instructions for the first new Alzheimer's drug in nearly two decades, recommending the therapy be given to people with early stage symptoms of the disease. Now. That makes sense because the drug was only studied in people in early stages. What's interesting about it is by a gin company that makes the drug their stock actually went up on this news. Because I think the market might have been thinking that the pressure on the FDA to reverse their approval of the drug was so intense. The FDA might change their minds and then Bajan would get crushed because a lot of their drug pray A lot of their stock price is based on people spending $56,000 a year per patient for this drug. So I think the market is relieved that the FDA Appears to be continuing. To support its use, at least in some population. In this case, the early stage population The Wall Street Journal says this could also make it easier for Medicare. To limit the billet faces from ADO Helm in coming years by restricting the number of patients who take it by a gin disclosed the label change yesterday. So I think that's a good move. I think it's a good start. I do think that Most likely this drug should be unapproved. Just based on the data and the price again. You want to pay for any drug for yourself that you want. Go for it. Don't make me pay for it. If you missed it.
"$56,000" Discussed on Bloomberg Radio New York
"In Hong Kong 9 30 here in Sydney. I'm Paula and I'm Doug prisoner at the Bloomberg Interactive Brokers Studio in New York will get trading under way at the top of the hour in Tokyo, Sydney and Soul. After a little bit of weakness in the U. S equity space, We'll talk more about market action when Brian Curtis joins us in a moment or two right now, a few of the Sauer's top business stories Paul with the FDA approved a new label for Biogen's controversial Alzheimer's drug. The earlier label for the drug addled helm was criticized by some doctors for being an overly broad approval. Bloomberg's David Wilson tells us what's changed. Today, There's a tweet to the labelling for this drug to focus on mild cognitive impairment, Mild dementia and Bijan points out. That's what they were really focusing on when it came to those two trials that those kinds of patients were the ones they were looking at. So You know, this is kind of a step to sort of clarify the situation and arguably it works in favor of the company because, you know, it's really focused on those patients. Then maybe they have an easier time when it comes to getting that $56,000 price tag covered by the insurance companies, the federal government whoever would end up ultimately paying the tab here. Biogen shares were up nearly 4% on that news. Chinese companies listed here in the U. S. Will reportedly get a new central regulator in Beijing. The Cyber Space Administration of China will be taking the lead on oversight, this reports to a central leadership group chaired by President Xi Jinping. Now the agency was set up during Xi's first term. Its mission police the Internet well now The Wall Street Journal says the organization will strengthen interagency oversight, especially for those companies traded in the U. S. It will also tighten rules for future foreign listings. So it would appear any plan deemed to threaten Chinese national security would presumably be blocked. Now, the change in regulatory authority seems to highlight Mr She's escalating effort to control the private sector, especially those tech companies with reams of valuable data. China's inflation data is expected at 9 30 Beijing time. That's in the morning at 9 30 PM Wall Street time. Bloomberg's Rosalind Chin's got a preview. China's consumer price inflation likely continue to pick up in June. Economists surveyed by Bloomberg estimate a 1.2% rise in CP from a year earlier. That's buoyed by higher prices of non food items. But lower food prices, particularly pork may have offset it to some extent. Meanwhile, producer price inflation probably called down Economistsforecasts 8.8% rise in PP from a year earlier that follows a record high of 9% in May. In Hong Kong and rustling chin Bloomberg Daybreak Asia 33 past the hour as we cross to Hong Kong. Brian Curtis is looking at market action. And what are you saying? Well, I mentioned this earlier. I think you might have missed it because I know you were checking markets very closely. But China's dovish tilt yesterday, you know, maybe that also kind of incentivize traders to think that the global recovery is a little weaker than we think. And that's one of the things that we've seen. Running through markets and the covid variant is becoming more of a market concern. And it's kind of exacerbated this trend of of some of the repositioning in markets investors have actually been doing for about five weeks. Doug, which is Is to trim on some of the value stocks that they loaded up on cyclicals and to buy into some of the mega cap growth. And that was really, um in in very sharp. Uh, you know, Picture today where they just sold everything really? I mean, everything was down all 11 sectors in the S and P 500 were down. So today it wasn't an either or it was just lighten up a little bit and see what happens. So it'll be interesting to see what happens with that inflation data coming up a little bit later in China. If we look at the futures here in Asia now we've got to Hang Seng Index Futures up 4/10 of 1%. Put in China a fifties up about 1/10 of a percent, but just about everything else down despite 200 futures in Sydney, down two thirds of 1% and Nikkei futures well, they are trading at a discount of about 1% plus two the cash So if if that holds true, we'll see the Nikkei opened more than 300 points down. Here at the top of the hour. The dollar was stronger, but so was the end, Dolly and now one of 9 83 yield on the 10 year all the way down to 1.29% and wt crude at 73 19. I still think it raises a very interesting question, You know? Is this a real global growth scare? Or is it just a little repositioning a little Tweaking of your numbers, and perhaps reopening slows down. Just a little Paul back to you. All right. Thanks very much. Brian, now 9 35 here in Sydney 7 35 in Hong Kong and time for Jake of Global News. And.
"$56,000" Discussed on Bloomberg Radio New York
"Seoul in Tokyo and then three hours to go before Uncle in Shanghai start to trade. We had such a sharp down day in Hong Kong and China markets yesterday that will actually see a little relief expressed and in the future is there But that may be pretty rare for what we see overall today in Asia and saying index futures are up about 4/10 of a percent. The banks and tech index tumbling almost into a bear market. So today could prove quite interesting. We'll get more on that with Doug Prisoner when we get to him in a few moments at the moment, Paul and I will take a look at some of the top stories of the hour. The FDA approved a new label for Biogen's controversial Alzheimer's drug. The earlier label for the drug, Aldo Addle Helm was criticized by some doctors for being an overly broad approval. Bloomberg's David Wilson tells us what's changed today. There's a tweet to the labelling for this drug to focus on mild cognitive impairment, Mild dementia and Bijan points out. That's what they were really focusing on when it came to those two trials that those kinds of patients were the ones they were looking at. So you know, this is kind of a step to clarify the situation. And arguably it works in favor of the company because, you know, it's really focused on those patients. Then maybe they have an easier time when it comes to getting that $56,000 price tag covered by the insurance companies, the federal government whoever would end up ultimately paying the tab here. Biogen shares up nearly 4% on that news. All right, Let's take a look at this one very interesting. Indeed, Chinese companies listed in the United States will reportedly get a new central regulator in Beijing. That's according to a piece in The Wall Street Journal. The cyberspace Administration of China will be that new watchdog it reports to a central leadership group chaired by President Xi Jinping. Now the agency was set up during Xi's first term with a mission to police the Internet. And sources are saying that the organization will strengthen interagency oversight, especially for the companies that are traded in the United States. It will also tighten up rules for future foreign listings. So any plan deemed to threaten Chinese security would presumably be blocked. The change in regulatory authority highlights Mr She's escalating efforts to control the private sector, especially tech companies with rims. Valuable data. China's consumer price inflation likely continued to pick up in June. Economists surveyed by Bloomberg estimated 1.2% rise in CP from a year earlier, and that's buoyed by higher prices of non food items. Lower food prices, though particularly pork off settle this to some extent. Meanwhile, the producer price inflation probably called down economists forecasting an 8.8% rise and keep me from a year earlier. That would follow a record high of 9% in May. So this data expected 9:30 a.m. Beijing time. 9 30 PM Wall Street time, Brian All right. I know that Doug prisoner has been diligently scanning the markets for all the latest and he joins us now, with some pearls of wisdom. I don't know about the pearls of wisdom. Let's talk about the bond market first and the anxiety about the growth outlook, especially given the fact that we're seeing spread in the delta variant. And any time you talk about a slower rate of growth, and maybe a little confidence that the Fed is going to do what it takes to keep inflation under control. Those worries about prices getting out of control seemed to have evaded at least here in the near term. And so today, the long term interest rates were down with the 10 year Treasury at 1 29. And that in turn weekend the financial is not a big surprise. There. We had the S and P Financials index down about 2% interesting, too, that the drop in rates recently has been correlated with a decline in travel and leisure stocks. The Dow Jones U. S Travel and Leisure Index today was down. 1%. So we had the S and P and the NASDAQ each down from record highs, the S and P off 9/10 of 1% NASDAQ, Calm down 7/10 of 1%. The Dow was off nearly 8/10 of 1%. We did have a recovery in crude oil. The government reported an unexpected drop in U. S inventories, along with record high demand. And so w t A in New York picking up about 1% right now, trading 73 21. Some dollars Weakness. Bloomberg Dollar spot Index Down about 2/10 of 1%, But look at a much stronger yen in New York trading the end gained about 9/10 of 1%. We've got a 109 handle now. 1977 futures in Chicago for the Nikkei finished down more than 300 points below where we were yesterday in cash. So I'm going to say that we're in for some tough sledding. Some of the dollar weakness, though, may have been attributed to what we heard from the East db. This is kind of interesting because they signaled the continuation of ultra loose monetary policy. Their inflation target has been raised to 2% and the baby said it would tolerate Moderate overshoot, and we had a much stronger euro. As a result of that here at a buck 18 49 kind of a curious development will talk more about markets in 15 minutes, Paul to you. All right. Thanks very much, Doug. We have it is now 8 35 in Sydney 6 35 in Hong Kong, And it's time for Jake a global news. Adviser.
"$56,000" Discussed on News 96.5 WDBO
"Lot of criticism for not visiting plunge. Eric Shobin will be sentenced later on for killing George Floyd last year. That sentencing hearing begins around 2 30. We'll have an update on Orlando's evening news at six. Don't wait for hurricane to be on your doorstep prepared. Now Download the wdbo and tap the beef are contracting Hurricane Guide get the latest updates, track storms, preparedness tips and more Wdbo and Mark Spain real estate. To help you get through another hurricane season when there's no power, TV or Internet you're only reliable source for information during a hurricane wdbo. This is where Orlando turns first for severe weather Wdbo. Do you suspect that you might have cataracts? The Fedotowsky Eye Institute has people coming to see them from all over the world. They offer refractive Lens exchange, which, like their cataract procedures can be a better long term vision solution for adults. 50 plus The Filipowski Eye Institute has performed over 56,000 cataract surgeries. Text Joe 2868686 and Schedule your consultation today. Text Joe 2868686. Here in the Sunshine State. We live in two time zones. We cheer for three NFL teams. We have over three million men over the age of 45 over half suffer from e D or P. E. If you're having problems in the bedroom, you'll see results on your first visit at Premier Men's Medical Center Guaranteed or your consultation is free. Listen to a specialist in men's health. I'm doctor, some of it If pills like Viagra have let you down,.
Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval
"Could get cheaper price tag of $56,000 a year was set by Biogen for its treatment. But now a drug by Eli Lilly has been fast tracked by the FDA and the competition's expected to drive prices down. Word of the competition drove Biogen Stock down 6% Eli Lilly jumped 7%. Google
"$56,000" Discussed on KOMO
"Clayton Neville has details. The survey was conducted at the Western Conservatives summit in Denver over the weekend. 74% of attendees who took it said they would approve of Florida Governor Rhonda Santa's for president in 2024. Close behind former President Donald Trump at 71%. In third with 42% approval was Republican Senator Ted Cruz of Texas. Mike Pompeo and Senator Tim Scott came in after that. Santa's has garnered national support from Republicans for his response to Covid and his hesitancy to impose shutdowns. Neither Trump or two Santas have announced bids for the presidency. But Trump has indicated that his supporters will be very happy. I am Clayton Neville. The backlash and fallout continues over the FDA approval of a controversial drug to treat Alzheimer's at 12 Till Jim Rupe reports from Los Angeles. It's called and you can you map approved by the Food and Drug Administration in spite of its advisory board, advising against it, the medications simply don't work. Amy Lee Amos is a dietitian and founder of the Amos Institute specializing in a functional medical approach, a systems biology, approach, diet and lifestyle in the treatment of cognitive decline. And Alzheimer's disease, she says. Not only is the drug and you can you mad ineffective, but it has some really dangerous side effects among those side effects, brain swelling and brain bleeding, and this isn't just her opinion. Dozens of doctors and scientists during the public comment period of the accelerated approval process voiced the same concerns on ineffectiveness and dangers with the drug. And not only that, she says, But the price tag is just as alarming $56,000 per patient per year just for the drug alone. Other costs will be the pet scan needed to diagnose it. And she says the yearly MRIs needed to watch out for the dangerous side effects. So this is going to cripple our health care system and potentially increase Spending by over $100 billion annually. It'll bankrupt families, she says at.
Biogen's New Alzheimer's Drug Is a Medicare Budget Buster
"New drug for Alzheimer's comes with rather controversial approval, and now we're learning a huge price tag. The drug is called Adele Adele home, I should say adult film. It was approved by the FDA last week. It's $56,000 per year for a supply. Medicare copays could reach $11,000. The Alzheimer's Association's sharply criticized the manufacturer, Biogen for that price tag. You're about to hear from Paul Seagirt. He is with PCs advisers there in Northern California firm. They help businesses manage health care costs, And he says, This is a perfect example of what is wrong with how we approve and distribute drugs. We've got great health care how we pay for? It's crazy. This is a perfect example. You've got a $56,000 drug that the FDA is just approved. Three of the scientists who were on the review panel That made a recommendation to the FDA have resigned because of the 11 in November, 10 said. No, I'm recommending to approve it and one said, I don't know. And yet they still approved a drug that Has, you know, really hasn't shown itself to be effective. They're going to build $56,000. A year for each person that's on this drug. It's incredible. The FDA advisory board gave the thumbs down to this drug. Yet it got approved by the agency. The question is why It's a great question, and unfortunately, I There's a lot of financial drivers that drive our whole system. I'm a free market person. I'm not against that. But we've a lot. We're approving this thing and then saying we're going to allow them to do a nine year confirmatory trial. Which in those nine years if they do end up confirming that it is not Very effective or not that effective or not at all, effective. We're gonna have spent hundreds of billions of dollars at that time frame. We're
"$56,000" Discussed on KIRO Radio 97.3 FM
"A uptick in appointments through vaccinations since the lottery, you went into effect, Governor Jay Inslee says Monday. This week. Just one day before the first lottery drawing, the state saw the highest number of vaccine appointments in two weeks. Hensley says more than half the state's total population has had at least one shot. And he says there's a chance the state could fully reopened sooner than his June 30th promise. That's if the trend of vaccine demand continues. Seattle hit the herd immunity goal, the first major city in the US to do so. It doesn't mean Seattle can fully reopened. But the mayor is still celebrating and closing mass vaccination sites as we hear from Cairo seven TVs Alison Grand 18. This milestone was critical for our city to start the process of reopening and recovery. In west Seattle. 82% of the population already has their first shot. The West Seattle side alone gave out 56,000 doses. The reason that we're closing is because we've just seen a sharp decline in demand. Now they'll do pop up clinics throughout the city are vaccine work is going to continue through the summer on mobile teams even here in West Seattle. The West Seattle site will be closing due will be closing and doing testing. Instead, Lumen Field will host its last mass vaccination event this Saturday, a little return to normal for Seattle. That's jazz Ali reopening this afternoon. The club had been closed for a year due to the pandemic. After tonight's reopened, more shows are planned through the.
"$56,000" Discussed on KIRO Radio 97.3 FM
"Isn't just an influx of people at the southern border. There is also a flood of drugs record amounts of opioids along the Mexican border. Drug cartels are seizing opportunity. The cartels are exploiting our current influx, and they're bringing hard drugs. Border Patrol agent Joel Freeland says US. Manpower focused on human smuggling is enabling traffickers to move staggering amounts of drugs, including £59 of highly lethal fentanyl seized by Texas troopers. The last six months. If that almost £60 of fentanyl had reached the streets, what could have been the result? Mass casualty fentanyl seizures have jumped 800% in Texas, Janet's family and CBS News El Paso in Idaho, a dog missing for two days after a car wreck has been found. Social Media helped track down Tilly found at a nearby farm where the border collie mix was hurting sheep. That's the roundup. I'm Steve K Thin CBS News now from the Cairo Radio News Center at my Northwest. Com Seattle Mayor Jenny Durkin is celebrating the vaccination record that has Seattle at the top. Cairo seven TVs Alison Grandi reports reaching this milestone was critical for our city to start the process of reopening and recovery in West Seattle. 82% of the population already has their first shot. The West Seattle side alone gave out 56,000 doses. The reason that we're closing is because we've just seen a sharp decline in demand. Now they'll do pop up clinics throughout the city are vaccine work is going to continue through the summer on mobile teams, even here in West Seattle, The West Seattle site will still be doing covid testing. We have seen a uptick in appointments for vaccinations since the lottery, you went into effect, Governor Jay Inslee says. The day before Washington's first vaccine lottery saw the highest number of vaccine appointments in two weeks in, Lee says, more than half the state's total population. Had at least one shot now to the winner of our state's first big cash prize for Covid shot will be submitting their prize claim today as Cairo radios. Diane Death, Wyler reports at this point, that's all we know. The state lottery office tells us it's still unknown. If the winner of Tuesday's $250,000 cash prize will go public. There were more than 200. Other prizes given away in the first of five shot of a lifetime drawings and calls to many of those winners have gone straight to voicemail. Unclaimed prizes will be up for grabs in future vaccine lotteries the next one next Tuesday. There are three more drawings at a top prize of $250,000.1 for a cool million in mid July. State senator is calling on his fellow lawmakers to conduct a hearing into December oil train derailment and Custer after some experts have come forward, saying it was sabotage. I think it's the Legislature's duty to take into the facts and to find out what's going on so we can take proper actions, the Legislature number one to condemn these types of activities and number two to look at legislation that might be necessary to get tough on these types of actions. Republican Senator Doug Ericksen says. In recent years there have been increasing instances of activists placing shunts on tracks and welcome county to stop oil and coal trains. Now to a former Seattle resident that has pleaded guilty to arson at the Seattle Police. East Prince inked. Isaiah Willoughby was charged for setting fire to the outside of the building during last summer's occupied protests, known as the Chop. He's been in federal custody since his arrest in July, will be faces up to five years in prison when he sentenced this October. The employment Security Department has a new commissioner Governor Insley appointed appointed Rather interim commissioner, Comedic FEEK, who has been at the helm since February to take the role permanently. She's got all the prerequisites. We need to navigate this department through the difficult challenges that they have, and she's already made substantial progress. Former commissioner Suey Laban Susie Levine left the role to join the Biden administration this past winter. After a troubled year at the SED that saw hundreds of millions of dollars paid out to fraudsters and some of Washingtonians waiting months for benefits. It's now 5 13. Time for Cairo. Radio. Real time traffic. Good morning, Harmon Shea. Good morning, Katrina get started, Everyone we have a couple of unfortunate situations this morning. Going on the freeway Traffic looks pretty clear. The highway 99 south coincide in federal way is closed. This is between South 351st. And 352nd street in the south End of town. Apparently a car at a pedestrian have been counter overnight. The pedestrian was killed in the long investigation is underway there the north outside of 99 years open. Stick with high five. That's the obvious altered it through their it. It's fine at Highway 4 10 has shut down completely both ways. At Highway 1 65 just before cemetery Road eastbound. And in the same area the other way. Apparently they've had a bad crash there, and that's being investigated. Health and in Seattle, Fifth Avenue's North bound Lane is closed approaching Mercer Street. They're still working on what's left of that big building fire that happened on Tuesday and reignited yesterday morning. This report, sponsored by Discover Want to hear something amazing Discover matches all the cash back. You were in your credit card at the end of your first year or more. Discover dot com slash match limitation supply. Kyra Radio. Real time traffic on the threes. I'm Harvard shirt for your forecast. It's partly cloudy with a few showers. Highs are in the sixties. Right now it's 54 outside the Carter Subaru studio coming up Should selective service be made gender neutral. The Supreme Court decided to duck that question..
"$56,000" Discussed on Bloomberg Radio New York
"Here in Bloomberg Radio, John Tucker, and that is your Bloomberg Business Flash Baton, Paul Bloomberg opinion informed perspectives and expert data driven commentary on breaking news. All right, we talk about our good friends of Bloomberg opinion. We talk about the work so highly because they put out some great great stuff, and I always recommend that I would recommend that you check it out of Bloomberg dot com slash opinion or O p I and go, but I'll tell you the column of the week. If not, the month was yesterday from Max niece and his biotech pharma and Healthcare columnist for Bloomberg Opinion entitled Approving Biogen's Alzheimer's drug is a big mistake and just as the title implies. Max pulls no punches punches. Mac joins us here in a Bloomberg Interactive brokers studio right now, so, Max again it was the stock was up. Everybody was happy. What do you think the FDA may have gotten wrong here? So there's definitely a lot of eagerness at the FDA and broadly to get the news Alzheimer's treatment on the market. There's nothing now that does anything but but alleviate symptoms. So there's this big, unmet need. Everyone wants her to be a success. But in this case, the evidence behind the idea that this drug works is at best, very contradictory and at worse. You know entirely inconclusive about its benefit. There were two trials of Biogen ran. Um, initially, they they halted both of them. They said we did a statistical analysis. It looks like there's almost no chance they're going to work. Then he came back a few months later and said, Wait a minute. Data continue to trickle in. And one of the studies is positive that creates problems in the first place. It it it muddies statistics. It means that they had far less data than they intended. Actually show a robust effect. And you want really good data here because you're not measuring like a tumor size or deaths you're doing on these complicated cognitive questionnaires, so there's already some sort of fuzziness in the data. And then you you have that second study complete failure. So there are two explanations for that One is the good study was right. The second one is that the failed one is right. Um, the FDA decided not even to really address this. They approved the drug based on the fact that the medicine cut amyloid plaques, which is a whole other thing, because that which is that's not a confirmed Theory about how Alzheimer's can be treated. It's a hypothesis and one that wasn't confirmed by Bajans data only made more confusing. So it was really a strange and puzzling decision. And this is one of the problems Max right because Now that this has been, um, past that this has been allowed through many of the other companies working on some kind of cure or treatment for Alzheimer's, are going to start funneling there. R and D dollars at amyloid plaque, and it may not even be the problem. Exactly. And this has been a problem for for Alzheimer's research for for decades. Everyone went straight at the amyloid hypothesis because it was our best idea. Because this is a really complicated and poorly understood disease. But we have you know decades of results suggesting that maybe this it shouldn't be the right target and that that wasn't resolved by Biogen. But now the FDA with this decision And without really any any backing from experts decided that not only is the amyloid hypothesis, you know good enough to see a drug approved. It's good enough to approve the drug with very few restrictions on who can be prescribed it, which means that it's likely to be prescribed very broadly, which comes with Lot of associated costs, considering that it costs $56,000 on average per patient. Yeah, that's that's a that's a big issue. Why do you think the FDA ruled the way it did, Max? I mean, as I just a lay person here. It just seems to me that the FDA is a very tough hurdle to get FDA approve. Other countries are approving things left and right, but the FDA you really have to have your egg game it usually is, you know, they sort of are a global standard center. In this case, All I can think of is that they they just felt that there's You know this this need that's so acute that they can have a lower standard of evidence. Even the chance of something helping is worth it given You know how many people with Alzheimer's are and how to help you options to have at the moment, But, um, you know, given the associated costs and and the the the level of evidence here that that's just way too big of a bridge for for me to cross and I was quite frankly shocked that that they created the approval. We'll do you not have deeper concerns Max about The FDA and I mean there are billions of dollars up for grabs here. This is a $56,000 a year treatment and You know, when there's a lot of money out there. You never know what people are going to do in order to get it. Yeah, absolutely. This is a bad precedent and a bad incentive. Um, there's for example, physicians have a lot of incentive to prescribe the drug because as part of Medicare part D, they get an extra add on payment of 6% of the drugs. Average costs. And patients are going to push for it. Even if insurers or Medicare itself tried to, you know, limit the use to the very narrow population in which you have contradictory evidence of benefit. Going to have a hard time to do. So it's hard to say no to drugs in the American healthcare system. So the FDA being willing to use this this some biomarker this unvaccinated biomarker for approval. This is really a concerning precedent..
"$56,000" Discussed on Bloomberg Radio New York
"For Bloomberg News. He joins us on the phone from New Jersey. So Bob for people who haven't been following the space as closely as you have take us back a couple of years about the bet. That Biogen made on the drug that was approved by regulators yesterday. Yeah, So all you know, research have been trying to design a drug to target the pathology behind Alzheimer's disease for decades and drug after drug drug has failed, and thousands drawn just two years ago looked like it was just the latest in a long line of failure as they stopped their trials earlier, they said. They didn't look like they're going to work. And then, eight months later, they shocked everyone, They said. They re analyze the data and look like one of the trials that may have worked and we're going to apply for approval change their mind going to apply for approval. We think that the strike approved and then it's been super controversial since then, and, uh, a lot of debate whether this drug works, But yesterday the FDA approved it, and then the bargain priced it at a very high price. And now there's a lot of controversy going forward of who should get this drug and you know whether it works at all well, and you've been covering this what Biogen has been up to with Alzheimer's You also for those Who are loyal listeners and watchers of Bloomberg, you Bob had been keeping us up to speed when it has to do with covid treatment and covid vaccines. There's been many cover stories by Bob Landrith. At Business Week magazine. What's interesting, though about Biogen Bob is that it seems to be as you guys and you specifically report that the approval, the FDA approval appears to signal a fundamental shift in the way the agency thinks about Alzheimer's disease, and this could have lasting ramifications as you report for other drugs. Whether it's over at Eli Lilly, Roche and elsewhere. Yeah, So for years, drug covers, including Bayesian have been trying to prove that a drug for Alzheimer's would actually slow cognitive decline. It's been really, really hard to do no one's really gotten clear evidence and housing jobs there. Two trials didn't really prove it, either, because one essentially failed to prove that the other was still controversial because it was stopped earlier that showed a very potentially a very small effect, installing caught his decline, and no one could agree. You know what to make out of it. And so what happened is after he has faced a lot of pressure from pain. Includes the Alzheimer's Association approved this drug. They're saying there's nothing out there. We need something. We're willing to take some uncertainty except some uncertainty. What they decided to do, is they they essentially in a surprise, they did not rule on make a verdict on whether this drug so it causes decline or not. Basically, the FDA said, We're going to prove it because it removes these amyloid plaques in the brain change some of the changes from this fund. Fundamental pathology, and we think that that is likely to have a reasonable expectation that I'll do something good in terms of patient outcomes in the future, But we're gonna have to wait for future trial stacked. Prove that it does seven. That was a big surprise. That's a big change. It is a big change in a reasonable expectation that it will actually have a positive result is not necessarily proof in a clinical trial that it does, and I wonder how this changes the way that The FDA approves therapies moving forward, especially at a time where there's so much skepticism around federal agencies in the wake of what happened with Covid. Yeah. So this this this This was going to be very controversial. Uh, you know, some people are already saying that it was a mistake. And this You know, could set a precedent for other kind of neurological disease, other neurological drugs and other drugs for Alzheimer's, Because now, they said, for Alzheimer's, you don't have to prove that the drug. Those cartons declined to take out on the market. You just have to show some evidence. It does something to bring pathology, even though there's a great controversy there with that brain. Pathology. How well it correlates with common has declined right. It's a big deal, right? So you know, not a cure. We get that right. But maybe in some ways like and you do wonder if the FDA is kind of allowing a little bit of wiggle room with some of these things, because maybe there's a little bit improvement. Or maybe there's a lot of improvement, you know, or at least stemming The degradation, right, Bob, you know in some patients Yeah, so the way you think about this, this is not a drug. Even the absolute best cases area under the most optimistic projection. It will not stop the decline. People are still declining steadily. But maybe Navy Maybe it slows down a little bit. Uh, and that's what they're saying that that's what the Alzheimer's Patients that I talked to one. They're saying there's nothing out there. We want something of this, You know, may slow the decline a little bit, and this is good enough for willing to take some uncertainty to improve it now, and that's what happened. You know, It's very controversial, very interesting. But it's funny because I'm going to talk about a stock gain or later, cassava sciences and They had no products in the market for 20 years, But apparently they're working on an early stage Alzheimer's drug and I think are getting a bit of a pop because of what happened specifically with Biogen's drug, so it is making everybody look especially when it comes to Alzheimer's Bob a little bit differently at the space and and in terms of treatment. Yeah. Other stocks growing up. I only went up yesterday because they have a similar Alzheimer's drug. And just going into phase three trials As they went up on the prospects, they might be able to get an approval sooner. Uh, so so no, no question there is, uh, you know, potential ramifications. You know, across the industry about $56,000 for a course of this. It's just a massive amount of money. Uh, What typically happens with the drug price. Does it go down after a few years? Just got about 30? Seconds here now, the drug prices. I mean, as far as far as far as we can tell, basically, never go down. They promised not to raise it. But What I can say is, is at least a million people in the U. S. It could theoretically qualifier this drug cost $50,000 a year. Do that math of everyone in that theoretical Who gets it? That's 50 billion. Wow and you talk about expensive brain scans and then to administer the infusions. It's not an inexpensive process. Hey, Bob, though, thanks for just digging deeper into this to explain why, though it has been so significant, we've certainly seen the stock pop yesterday a little bit of a pullback in today's trade when it comes to buy Virgin, but definitely watching it Problem with health care reporter at Bloomberg use on the phone in New Jersey. Let's get a quick check of.
"$56,000" Discussed on MAD MONEY W/ JIM CRAMER
"Being back down again there was so much symbolism to be on the floor of the new york stock exchange may feel like the old days where the action is. What's the real point of all this wall street. I don't want to get to existential down day at were. The prospect of higher interest rates spooked the market dow slipping one hundred twenty six points. Some people climbing on point eight percent nashik actually dancing point four nine percent but for me it was that double wall street homecoming. The first time. Being when i was hired by goldman sachs almost forty years ago. The second time shortly after the legendary mark haines passed way. And i started working on squawk on the street grant. It was a bit jarring sitting side-by-side partners. Carl david reunited for the first time since the pandemic hit the floor. Slow down. they're being careful which i like but it still got. What made me want to come there in the first place. So pairs took me to the gallery. When i was five no security back then and a nice trader gave me a role in the next time i went as an employee of goldman sachs where it was a helpless be knocked over repeatedly by clerks wanting to place orders knocked over until i guess they fell by wasn't worth not over anymore these days. Much of what what. Electron electric the stock market equivalent. Of kramer fave trait web does for bond trading on that later but the excitement still there what drives it well in some cases it stocks like game stopping. Amc stunning moves as they're being bit up by throng it just keeps winning. Both companies have taken advantage of the to raise capital order to fix the ballot sheets. Go on offense. We don't know what game sox planning we're find out. Maybe when they're putting but amc wants to become the most powerful movie theater chain in the world perhaps is part of a larger hospitality scheme maybe ceo. Adam aaron gets it from his history running vail resorts starwood hotels enriching whose lights to say nothing of a successful ownership stake in the seventy sixers where he trusted the process that has been the playoffs. All those are compelling story especially thinly traded market like this one where somebody professionals are still in vacation. Make it easier for the home. gators gamer. Stitches really assert themselves not takeover more important though the new york stock exchanges both real and symbolic functions the exchange introduces initial public offerings. At least the ones that they one versus the nasdaq and there's a tremendous. Excitement is for traders crowd around the new post of where the offering is to figure out what it's going to open it. Now we're post nine. What's a hub of trading. Now we witness the principles of new puppies ring the bell joyce bowman filled with promise even if that promise sometimes miracle the second thing that goes on though is what i love today because it suggests the pandemic maybe weaning. I'm talking about people jawboning over the price of goods to get the best price for the customers on a daily today that means giving traders big accounts. What is a picture what a stock looks like whether there are big sellers where buyers by be willing to pay higher prices. Now you can't give secrets in twenty years and training going never knew who was on the other side. That's for big. You just want to feel a sense that you're going to see a curveball upper. Maybe something that bill nowadays is possible that most council even care about what's known as a floor look because so much has done electrically but if they care enough to ask today what is seen more sellers than buyers. Okay that's a funny phrase. That sounds like circular reasoning. Why stocks go down oh more sellers than buyers that some keenan say. You really don't need kramer for that one but you want to chew. Listen to me. There are many big accounts who are selling stocks. You're far more than those. Who are interested in buying them at these prices so the sellers have no choice but to accept lower prices. Something obviously don't want their always hoping that more buyers will step in however this weekend treasury secretary janet yellen former fisher said that this economy strong enough to handle or even welcome higher interest rates. Well that's what causes sellers. Just what's notice kit bids all over the place. Knock something down. Let's say you're talking about a stock like new the steelmaker largest in our country. It's the second best performing the s. and p. five hundred up roughly a hundred and five percent coming into today's session just got crushed. Those who own the stock might be thinking that a rate hike from the fed means that are cool and the price increases in steel will no longer stick because everything that uses steel other than infrastructure might be hurt by higher rates construction carlos more expensive transition. Fewer buyers help center. The owners will nucor terrific. Little insulated metal panels come today for a billion bucks. Something that's good for. Business may even sent the stock into further orbit or another day but today sellers overwhelm. The buyers hit all bids down to one point. One hundred five and change a week after the stock was at one ten now to me. I think it's fabulous to nucor has multiple years where it does well when the cycle gets. We bought some for the travel. Trust in follwoing by joining extras plus dot com club but the stock closed down more than a percent which put me in opposition camp. Although maybe an opportunistic one i think becomes. Cheaper is it comes down. Sellers obviously don't agree. Of course that's not how it played out everywhere we so buyers overwhelm sellers and eli lilly as biogen got a relatively easy. Fda approval foreign alzheimer's drugs. That might not even be as good as the one who is working on. We saw an oddity in the floor and this one buyers one furious moment willing to pay far more than sellers willing to sell out in other words they took several offerings to several dollars above where the stock was trading the seller simply didn't have time to cancel their offers something. We see almost daily in the red sox like amc game stop doesn't matter a lot of people ask that i think so. It can provide more orderly markets on the basis can give you actual referees if something goes wrong with trade is a very fair place to do business. The big box begun upstairs as they call it between the big brokerages however always be shrine to capitalism. It's best okay. Occasionally is worst and nothing. Or at least i hope nothing can ever take away from the simple beauty of traders fighting for you fighting to buy and sell at prices meet the demands of.
"$56,000" Discussed on NEWS 88.7
"It's on the minds of many Texans, in part because of the traumatic memories of February's deadly blackouts. But it's not only that When it comes to energy. Many Texans also wonder and even worry about what a federal move towards renewables could mean for a state where oil and gas have long played such a large role that is also on the mind of US Energy Secretary Jennifer Grant home. She's in Texas today in Houston, meeting with some industry leaders secretary Grand Home Welcome to the Texas Standard. Thanks so much. So glad to be here. I want to talk about the shift that President Biden promised to move away from oil and gas. And it's a scary thought. I have to tell you for a lot of people whose lives and even for towns that the local economies Depend on those industries totally get it. And that's why I'm so glad to be the secretary of energy at this time because the Department of Energy is known as the Solutions department, and that means for those who are, for example, working in natural gas. We want to help those companies and those individuals be able to Ensure that we have the ability to what is known as to manager sequester the carbon emissions that do result from natural gas. The bottom line is we want clean energy, and the source doesn't matter so much as the fact that it is not producing poisoning greenhouse gas emissions, So we've got solutions and we want to help that transition. And by the way, I mean, Texas Yes, you have been, you know, obviously the oil and gas capital, But you are also number one in wind. I know in the country and you know, we love celebrating that its solar right. We got to get your competitive juices flowing because California's beating you in solar and you have amazing resource is and you've got almost a quarter of a million people who are right now working in the clean energy sector in Texas, so that's really exciting. I know that today You're going to tour hydrogen planned and I wondered, you know, when you look at energy like solar, what wind and all this stuff. Is it possible for these? Yes, they're called green energy jobs to provide enough opportunities for Texans than what I mean. When I say enough, I mean enough to replace oil and gas for the losses, you know, let me just be clear. It's not that we want to do an entire replacement. It's that we want to make sure that the oil and gas sector Is carbon free and even many of like, for example, Shell announced that it was going to go net carbon zero by 2050, which is what the president's goal is for our overall economy, so these oil and gas companies they see where the world is going. They want to export oil and gas, but they want to export and had they want have customers. But 196 countries have signed on to this Paris agreement, which gets us This global commitment to net zero carbon emissions, So we want to help those companies and individuals transition. But let me just say in terms of people feeling like they ought to have good paying jobs and where the future is, I mean jobs as wind technician's pay $56,000 on average per year. If you are an oil working on an oil Derrick, it's about 47,000, so they're better paying jobs and their future paying jobs. We want Texans to see themselves as having played such an important part of powering our nation up to this point, and we want Texas to lead into the future and see themselves empowering the future of a clean energy economy. I want to ask you I don't know if you've been following the legislative process closely here in Texas, but how adequate do you see the steps that the state is taking? Towards preventing blackouts like the ones we saw. Well, first of all, I'm glad to see that the Legislature is taking this on about a decade ago, the state was warned. Obviously, this happened about a decade ago, a swell and the state was warned then about the importance of weatherizing winterizing the system so that you can prevent this from happening into the future. So I'm so glad to see that being addressed Everybody. All American families should be able to count on reliable electrical service to work when they when they need it. So the bottom line is the what the state is doing. I'm hoping that they are able to pass something that insists upon winterization. I hope that they're able to figure out a way where you don't see everyday citizens bearing the brunt of that. But obviously that's up to the Legislature. I'm just glad they're addressing it. And I would say one other thing because Texas's system as everybody knows his independent from the rest of the country, other than a part about you know, El Paso. Um, you know the country wants to be able to help you know that if there is a way to at least have some connection, and that way, Texas would be able to export wind and solar to other parts of the country as well as receive help. Is that your recommendation that the state should connect? I think there should be an a nun, Durst Anding or a conversation at least about what that might look like while still preserving the spirit of independence that Texas is so well known for. I think there is a way to do it on by hope. I hope that the Texas legislators, but the Texas system at least begins those conversations with US. US..
"$56,000" Discussed on 790 KABC
"We want to do business next door in Nevada, which has zero income tax, or do we want to do it in California? So undercount Kevin Focus plan As you said the 1st $50,000 that an individual learns or the 1st $100,000. In a married couple filing jointly would be tax free, free of any state income tax at all. And in California. The rates are so high that at $56,000, you are tax quote As a quote rich person you pay at $56,000 a year, the same tax rate that is the top tax rate. In New York, which is not exactly a conservative bash in so I think the tax cut proposal that Kevin falters put forward is the most exciting thing that I've heard of during this entire recall campaign going forward, and that alone is a reason. To recall Gavin Newsom intellect, Kevin Fault. That is so true. Don, you want to wrap up with a question? Yes, I do. What other proposals might we expect in the coming weeks? Well, you're going to see a several different proposals in a couple of different areas, all of which are designed to attack current problems. He's already come out and put out a reform proposal for the state's employment development Division Department. That's e D D. That's the unemployment insurance division, which has a massive problem It is it is. This. This Department of State government would make the Postal Service look like a model of efficiency. Kevin thought they're faced a similar problem with the 911 system in the city of San Diego. He's used to. He's seen a problem like this before. He's put out a reform proposals to fix Theo the employment development Department as well. You can expect Haven't fought him to speak to all of the top issues that are of concern to the state moving forward, but I don't want to. I don't want to spoil anything that's coming up, but I know that there are several very bold forward looking proposals that are coming out from Kevin fought there. In the weeks ahead, so and I think that these are as exciting as a tax reform proposal that he's already put forward Ron, we want to thank you for your time. We're getting near the end of the segment, but this has been really great. I think it's been very informational for our listeners. I want to remind our listeners I'm Jim Lacey, with Don Ramana. We're live and tax If Oranje and kbc 7 90 a m, you can call in with your questions at 1 802 22 kbc. That's 1 802 225222. We're gonna close this segment. Now we've We've got Linda in Burbank on line one. We're gonna ask Linda to just hold on through the commercials. And bring her back into the next segment. And again Thank you so much Iran and don, What's the music going out? It's the Soul Queen of New Orleans. Irma Thomas taking us out. Yeah, on an album that she way recorded Actually, here in San Francisco, it Slims. So, uh, Enjoy here on talk radio. 7 90 KBC.
"$56,000" Discussed on 860AM The Answer
"The service of bridge connecting people to programs and educating you on the role you play in utilizing expanding these programs as you'll hear me say time and time again. You need to go through the process. Submit your information so that you could be counted and considered as our leaders draw up community development plans in response to our growing housing needs. Want to ship is currently a game of musical chairs whereby homeowners are grateful to own a seat. Prices are out of reach of even the highest income earners. The out of reach nature of today's housing market is just another indication of how far out of line wages have gotten in terms of enabling households to pay for everyday expenses, let alone send their kids to college or plan for healthy retirement. Racial inclusion and diversity has morphed into economic inclusion and diversity. Macroeconomic factors like unemployment, inflation and gross domestic product really have people thinking that everything looks good if you talk to most of the people on Bloomberg or CNBC. I'll tell you, Macroeconomic Lee. We're doing pretty well as a nation. We've recovered from the recession. We're not at the growth levels that everybody is comfortable with. But at least we've grown. We're growing as an economy again. The problem is that most of us are affected by micro economic factors. This includes home building, you know, school's new businesses and employers and infrastructure. Today. We're really going to drill down on somebody's micro economic factors that affect this everyday talk a little bit more about what has happened since 1968. How much is this housing market has changed. Now We're talking about gentrification issues and the neighborhood makeup in places that people once could afford to live in whether they rent or own. Now they can no longer afford to live in the same neighborhoods. And we'll try to reflect back on this whole concept that we talked about last week of eligible household and really get an understanding for what expensive housing or affordable housing really means. And get an understanding for word. The program. Opportunities are for you is a household thinking about where you're gonna live. Not just this year, but 235 years down the line. Everybody knows the Bay Area housing market has reached astronomical prices. But I think people don't really understand exactly just how out of reach they've become. If you take one person in Alameda County at median income, that's a $68,000. Income. So if you learn right now, in Alameda County, 68,000 or less, you're considered a median income household if you weren't $56,000 or less You're considered a low income household. Have you earned $36,000. Unless you're considered a very low household and extremely low is anyone that makes less than 22,000 and that's in Alameda County. When you move in the San Francisco these numbers move a median income household earns $80,000 a year and I'm talking about when I say household. This is a household of one. So just you moving out of your parents making $80,000. Unless you're a median income household, you drop the 73,000 and low income 46,000 very low. Anybody making less than 27,000 is extremely low. If you go to the peninsula in San Mateo County. Immediate income household again Makes $80,000 a year if you go down south of Santa Clara County Immediate income household of 11 person makes 7 $9000 a year. So any single person out there in the Bay area, making between $25,000 on the very low end. And $97,000 on the high end, meaning a single person. We're not even talking about families because I think when I'm on the radio a lot of times you'll hear me. Talk about a family of two or three or four were just talking about a single individual out there, making $96,000 a year. You need to be concerned about the low to moderate income household policies in your community, because when they say low to moderate income households there speaking directly to you So it's important that we understand as we form our household. I'm really talking to the people that are forming households right now. They haven't quite settled down. Got married, had kids yet They're forming their household if you make less than $96,000 a year. It's very important that you get very familiar with low to moderate income household, especially when I think about the price is that people are paying for houses today and how much of their income they're devoting towards that housing payment. So listen closely. Today's show You want to make sure you visit us in house keys radio dot com Again. That's house keys radio, like, Come, I'm your host, Julius Nyanda. We're on am 12 20 K d O W Talking about affordable housing and really understanding how The fair housing movement that was really based on racial equality is now one that's morphed into economic equality again..
$259M Rent Relief Program Opens For los Angeles Residents Tuesday
"In rent relief thanks to a state bill that allocates more than $2.5 billion in rent and utility bill relief to Californians. Money can be used to forgive rent that wasn't paid in the past 12 months reimbursed landlord struggling from a lack of rental income or to help a current rent. Assembly member Miguel Santiago represents the 53rd district in parts of downtown in East L A and supported the bill. This is big news. Big news because renters will have the ability to have either rent forgiven or a portion of the rent paid so they don't get a victim. Now you don't have to be a documented citizen. You just have to live in l, a be financially affected by the pandemic and make less than half the area Median income, which is about $56,000, a year for a family of four. This will help thousands of families stay in their homes. The reason we're pushing this and the reason we're making sure that everybody understands the programs that are out there because that one big wait to prevent the homeless problem is to make sure people don't fall in the streets. Angelenos can apply online at H C I d l A Dud L. A City daughter work.
$260M Rent Relief Program Opens For Los Angeles Residents Tuesday
"6 30. Starting today, Ellie residents can apply for up to $10,000 in rent relief. It's thanks to a state bill that allocates more than $2.6 billion in red and utility bill relief to Californians. The money can be used to forgive back rent owed over the past 12 months reimburse landlord struggling from a lack of rental income or to help a current rent. Assembly member Miguel Santiago represents the 53rd district in parts of downtown in East L A and supported the bill. This is big news. Big news because renters will have the ability to have either wrecked forgiven. Or a portion of the rent paid so they don't get a victim. You don't have to be a documented citizen. You just have to live in l, a be financially affected by the pandemic and make less than half the area Median income, which is about $56,000 for a family of four. Fund is estimated to help about 64,000 families stay in their homes. The reason we're pushing this and the reason we're making sure that everybody understands the programs that are out there because that one big wait to prevent the homeless problem is to make sure people don't fall in the streets. Angelenos can apply beginning today through the end of April. You could do that online at H C I d hash L. A Not. Ellie. Citi
Tesla cars can be bought in Bitcoin
"Last month, the electric carmaker revealed that it purchased $1.5 billion worth of Bitcoin at the time, it said it would soon start accepting the crypto currency as a form of payment. Overnight musk tweeted that it could now happen After that. The price of a single Bitcoin rose to more than $56,000, an entry level Tesla model three costs just under 40,000. While the company's most expensive car a model X plaid starts around
"$56,000" Discussed on WBZ NewsRadio 1030
"Except Hopeful that X $56,000 or less in a year. No prepare and file their bedroom and state income tax for three. Lisa McFadden with Leo tells me this is the third year they've provided the service and they're seeing a big uptick in interest this year, in part because so many people Have been impacted economically by the pandemic. Carl Steven stop BBC, Boston's news radio and see Alan Georgia Right now battle for the Jones got very well respected Invitational golf tournament down South WBC's drama, Holland tells us the talk among the players is still Masters champion Patrick Re for those who don't follow golf. Reed found himself in the spotlight for all the wrong reasons last week, winning the farmers Insurance open after a controversial free drop, claiming his ball was embedded in the ground when probably not local. For Nick Mark Cario didn't like what he saw from Reed. Even though Reid asked for a rules official, he almost went to the ball looking for that ruling, right? I'm not once I quickly give out the designation of like you're a cheater. You'll lay in the bed you make essentially which I think for him is unfortunately happy now a little bit, And he says he thinks the PGA might want to reevaluate how lenient they are with some of these pros when it comes to the rules of golf, you know, it's interesting. I actually feel like the rules officials in mass and otherwise are a lot more stringent than the One of the PGA to work and look in Georgia today, by the way, Nick Mark Cario, the Jones Cup on the line True Mo Holland WBZ Boston's NewsRadio in Pandemic Times..